APA (7th ed.) Citation

P, L., SE, Y., IJ, M., EM, R., MK, B., BM, B., . . . DA, J. (2026). Antiadalimumab Antibodies in Patients With Inflammatory Ocular Diseases: Incidence and Clinical Outcomes. American journal of ophthalmology, 290, 1. https://doi.org/10.1016/j.ajo.2026.06.003

Chicago Style (17th ed.) Citation

P, Liberman, Yu SE, Mendez IJ, Ramos EM, Berkenstock MK, Burkholder BM, Thorne JE, and Jabs DA. "Antiadalimumab Antibodies in Patients With Inflammatory Ocular Diseases: Incidence and Clinical Outcomes." American Journal of Ophthalmology 290 (2026): 1. https://doi.org/10.1016/j.ajo.2026.06.003.

MLA (9th ed.) Citation

P, Liberman, et al. "Antiadalimumab Antibodies in Patients With Inflammatory Ocular Diseases: Incidence and Clinical Outcomes." American Journal of Ophthalmology, vol. 290, 2026, p. 1, https://doi.org/10.1016/j.ajo.2026.06.003.